Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circadin 2 mg for sleep disturbances in mild to moderate Alzheimer's disease
2009-014388-38Phase 2Completed
- Sponsor
- Neurim Pharmaceuticals
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Insomnia and Alzheimer's disease (AD) comparing Circadin 2 mg with Placebo (2 arms). Started Aug 2010; status: completed.
02
Drugs
melatonin
03
Conditions
InsomniaAlzheimer's disease (AD)
Beyond the preview
Go deeper on 2009-014388-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014388-38.